CGC Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3
| Closed | -$300 | – | 353 |
|
|
2024
Q3 | $300 | Hold |
3
| – | – | ﹤0.01% | 325 |
|
|
2024
Q2 | $253 | Hold |
3
| – | – | ﹤0.01% | 330 |
|
|
2024
Q1 | $219 | Hold |
3
| – | – | ﹤0.01% | 339 |
|
|
2023
Q4 | $214 | Hold |
3
| – | – | ﹤0.01% | 353 |
|
|
2023
Q3 | $180 | Hold |
3
| – | – | ﹤0.01% | 320 |
|
|
2023
Q2 | $216 | Buy |
+3
| New | +$216 | ﹤0.01% | 339 |
|